[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cns Pharmaceuticals Inc (CNSP)

Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cns Pharmaceuticals Inc 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 USA

https://cnspharma.com Employees: 8 P: 800-946-9185

Sector:

Medical

Description:

CNS Pharmaceuticals Inc. is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors. The company's lead drug includes Berubicin, for the treatment of Glioblastoma Multiforme and potentially for other CNS malignancies. CNS Pharmaceuticals Inc. is based in Houston, United States.

Key Statistics

Overview:

Market Capitalization, $K 7,921
Enterprise Value, $K 721
Shares Outstanding, K 1,461
Float, K 1,461
% Float 99.99%
Short Interest, K 39
Short Float 4.81%
Days to Cover 2.10
Short Volume Ratio 0.52
% of Insider Shareholders 0.01%
% of Institutional Shareholders 14.02%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -15,850 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,940 K
EBIT, $ -16,630 K
EBITDA, $ -16,630 K

Growth:

1-Year Return -60.55%
3-Year Return -99.99%
5-Year Return -100.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.93%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -7.30 on 05/14/26
Next Earnings Date 08/13/26
Earnings Per Share ttm -29.63
EPS Growth vs. Prev Qtr 28.08%
EPS Growth vs. Prev Year 61.51%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 07/22/25

CNSP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -238.68%
Return-on-Assets % -166.30%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 57.96
Book Value/Share 0.09
Interest Coverage -791.50
60-Month Beta 2.62
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.